secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2023-05-16T23:59:59+00:00
Accession:  0001683168-23-003473
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma closes $5M private placement, issues shares and warrants
---------------------------------------------------------------------------

- Issued 5,952,381 units at $0.84/unit; each unit = 1 share (or pre-funded warrant) + 2 warrants at $0.59 exercise price.
- Warrants to purchase up to 11,904,762 shares, exercisable at $0.59 per share, term 5.5 years from issuance.
- Aegis Capital Corp. received 10% of gross proceeds as placement agent fee, plus 2% non-accountable expense allowance.
- Company obligated to file resale registration statement with SEC within 15 days; liquidated damages for delay.
- Private placement closed on May 16, 2023 with a single healthcare-focused institutional investor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316823003473/0001683168-23-003473-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316823003473/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-003473

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer